BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8286749)

  • 1. Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers.
    de Boer M; Hilarius-Stokman PM; Hossle JP; Verhoeven AJ; Graf N; Kenney RT; Seger R; Roos D
    Blood; 1994 Jan; 83(2):531-6. PubMed ID: 8286749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox).
    de Boer M; de Klein A; Hossle JP; Seger R; Corbeel L; Weening RS; Roos D
    Am J Hum Genet; 1992 Nov; 51(5):1127-35. PubMed ID: 1415254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
    Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
    Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
    Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
    Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.
    Leusen JH; de Klein A; Hilarius PM; Ahlin A; Palmblad J; Smith CI; Diekmann D; Hall A; Verhoeven AJ; Roos D
    J Exp Med; 1996 Oct; 184(4):1243-9. PubMed ID: 8879195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
    Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
    Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
    Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
    Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
    Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the defective NADPH-oxidase component in chronic granulomatous disease: a study of 57 European families.
    Casimir C; Chetty M; Bohler MC; Garcia R; Fischer A; Griscelli C; Johnson B; Segal AW
    Eur J Clin Invest; 1992 Jun; 22(6):403-6. PubMed ID: 1633835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.
    Hossle JP; de Boer M; Seger RA; Roos D
    Hum Genet; 1994 Apr; 93(4):437-42. PubMed ID: 8168815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component.
    Erickson RW; Malawista SE; Garrett MC; Van Blaricom G; Leto TL; Curnutte JT
    J Clin Invest; 1992 May; 89(5):1587-95. PubMed ID: 1314852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease.
    Dinauer MC; Pierce EA; Bruns GA; Curnutte JT; Orkin SH
    J Clin Invest; 1990 Nov; 86(5):1729-37. PubMed ID: 2243141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
    Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
    N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry and molecular biology of chronic granulomatous disease.
    Segal AW
    J Inherit Metab Dis; 1992; 15(4):683-6. PubMed ID: 1528026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67
    Roos D; van Buul JD; Tool AT; Matute JD; Marchal CM; Hayee B; Köker MY; de Boer M; van Leeuwen K; Segal AW; Pick E; Dinauer MC
    J Clin Cell Immunol; 2014 Jun; 5(3):. PubMed ID: 25937994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.